By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Research, development and commercialization of its novel gene therapies and vaccines1.53M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States4.41M100.00%